glp-1 cv outcome trials Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Cardiovascular outcomes in major trials

PMID: 37392810

Abrupt discontinuation of stimulants can cause withdrawal symptoms and ADHD symptom rebound, whilst stopping Wegovy typically results in weight regain

Stopping the medication often leads to regaining lost weight unless lifestyle changes like diet and exercise are consistently maintained

The evolving landscape offers hope for the future of comprehensive obesity management, where increased accessibility and innovation in delivery services may further drive positive health outcomes

Individuals with diabetes are already predisposed to vascular complications so introducing semaglutide to the mix could cause such an injury

Monitoring for gallbladder issues is important during rapid weight loss